New Isolation Technology for Next Generation Vaccine Solutions
Our partner for barrier isolation technology, Tema Sinergie, recently completed an FAT for a custom sterility testing isolator for the Translational Research Institute (TRI) in Brisbane, Australia. The equipment will be installed in the new TRI Clinical Manufacturing and Training Hub, the result of a joint project between TRI and Vaxxas, a startup specializing in next generation vaccine technology.
The isolator perfectly meets the required flexibility to be used by start-ups and researchers for small-scale manufacture of early stage clinical trial products (including new generation vaccines, cell and gene therapies). The equipment will also be used as a training tool for staff and students in pharmaceutical aseptic manufacturing.
This hub will be used for early stage clinical trial manufacturing. Read the full article here.
Sign up to get the latest news on our pharmaceutical automation solutions.